June 24, 2023 Comments Off on New patent for Apellis Pharms drug EMPAVELI Posted in: Patent Added Annual Drug Patent Expirations for EMPAVELI Empaveli is a drug marketed by Apellis Pharms and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Apellis Pharms drug EMPAVELI appeared first on Dru…
June 24, 2023 Comments Off on New patent for Bausch drug DUOBRII Posted in: Patent Added Annual Drug Patent Expirations for DUOBRII Duobrii is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Bausch drug DUOBRII appeared first on DrugPatentWa…
